Sensitivity of Human Malignant Melanoma Cell Lines to Newcastle Disease Virus

PMID: 26408702
Journal: Anticancer research (volume: 35, issue: 10, Anticancer Res. 2015 Oct;35(10):5401-6)
Published: 2015-10-01

Authors:
Pap M, Bátor J, Szeberényi J

ABSTRACT

BACKGROUND/AIM: Virotherapy may be a promising alternative to chemotherapy of malignant melanoma. In clinical trials using strains of Newcastle disease virus (NDV), only a fraction of patients with cancer responded to virotherapy. In the present study, we tried to find a correlation between the susceptibility of human melanoma cell lines to NDV and growth factor signaling pathways.

MATERIALS AND METHODS: Using an ATP assay, cytotoxicity of an NDV strain (MTH-68/H) was tested in 13 human melanoma cell lines. The activation state of growth factor signaling pathways was studied by the analysis of key signaling proteins.

RESULTS: MTH-68/H was found to be cytotoxic in all melanoma cells tested, but the IC50 values varied significantly. No correlation between the IC50 values and the rate of extracellular signal-regulated kinase (ERK) and AKT phosphorylation and phosphatase and tensin homologue (PTEN) expression was found.

CONCLUSION: Susceptibility of tumor cells to NDV may be affected by alterations other than those of RAS/ERK and phosphatidylinositol 3-kinase (PI3K)/AKT signaling in uninfected cells.